top of page
Search

A Probable Spillover: Shamonda Virus in France

Writer: P.K. Peterson
P.K. Peterson
39 minutes ago
3 min read

“The first documented human infection with [Shamonda virus] SHAV in 2026 demonstrates that human infection is possible.”

World Health Organization, October, 26, 2026


“Spillovers have happened forever, but the opportunity for them to happen has increased, the opportunity for spread has increased, and the opportunity for impact has increased because we get older, we live longer, [and] we have immunocompromised people.”

Marion Koopmans, Scientific Director, Pandemic and Disaster Preparedness, the              Netherlands



On October 20, 2026, public health authorities in France notified the World Health Organization (WHO) of the first laboratory-confirmed Shamonda virus (SHAV) infection in a human. The patient, a severely immunocompromised older male, died of SHAV encephalitis on October 8, 2026. In this week’s post, I provide a brief refresher of the history of emerging infections and then summarize what is known about SHAV.



The big picture: emerging infections are not new. Of the estimated 1,400 human pathogens, approximately 40 have been identified as newly or reemerging threats to humans. The period since 1975 has been especially remarkable for the discovery of many new human pathogens, the return of old infections, and the recognition of previously unknown zoonotic diseases, that is, diseases caused by pathogens transmitted by animals. Many of these infections have been featured in earlier Germ Gems.


Two of the most consequential are the coronavirus SARS-CoV-2, which emerged in Wuhan, China in late 2019 and has caused at least 7.1 million deaths globally from COVID-19, and the retrovirus HIV-1, emerging in 1981 and causing the AIDS pandemic that killed about 44.2 million people.  Several older infections, including tuberculosis and measles, have also returned or expanded substantially.


The sobering part is the score: over the same period that roughly 40 human infections emerged, only one old infection “submerged.” On May 8, 1980, WHO declared smallpox eradicated, thanks to an extraordinary vaccination campaign.


Meet SHAV.  SHAV is an RNA virus of the genus Orthobunyavirus and is recognized primarily as an animal-associated virus. It was first detected in cattle in 1965, when it was isolated at the University of Ibadan in Nigeria, and is named for Samonda, then a village and now a neighborhood of Ibadan.



SHAV is a vector-borne disease. It is not considered to spread directly between animals but appears, instead, to be transmitted primarily by the biting of midges. (World Health Organization, “Shamonda virus in human-France,” Disease Outbreak News, November 2, 2026). Besides cattle, SHAV is known to infect sheep, goats, horses and alpacas, causing reduced milk production and reproductive disorders. Most often, it causes only mild illness in animals.


SHAV was detected for the first time in Europe during the summer of 2026 with confirmed or suspected infections reported in cattle, horses and alpacas. These outbreaks involved two genetically distinct variants, SAV-EU1 and SAV-EU2, spreading at the same time. Like over 60% of emerging infections, SHAV is zoonotic, and the cow is its main host. The suspected culprit for getting the virus from animals to humans is the midge, a tiny biting fly also known as the “no-see-um.”


The case: a “spillover” in eastern France. The first human SHAV case occurred in a rural area in eastern France where animal SHAV transmission had been documented since July 2026. The patient, an older man with a severely compromised immune system, was treated for encephalitis, an inflammation of the brain. His symptoms included confusion, visual disturbances, seizures  and loss of consciousness. He died on October 8, 2026. The case is considered a zoonotic infection, with probable “spillover” from an infected animal to the human it killed. According to WHO’s November 2, 2026 report, no additional cases have been identified.



Stay alert; not alarmed. Most public health experts agree that a single SHAV case is insufficient to assess the risk to the general population, including immunocompetent individuals, or to determine the frequency, clinical spectrum, or severity of human infection. But even if no further case of infection is detected,  “this spillover event should be seen as a harbinger of a bigger developing situation.” (Guenot, M., “First human case of Shamonda virus recorded,” The Lancet, October 31, 2026.)


The chances of SHAV triggering another catastrophic emerging infection appear to be slim. But, spillovers are as old as humans and animals sharing the planet. And, while one death in France does not make a pandemic, it does remind us that the next emerging infection will probably begin the way most of them have, with a germ crossing from an animal to a person who happens to be vulnerable.      

 

 

 
 
 

Comments


Subscribe Form

Home: Contact
Home: Subscribe

Main Page images courtesy of Shuxian Hu, MD. Dr. Hu is a scientist in the Neuroimmunology Research Laboratory at the University of Minnesota.

Home: Text

Blog design and IT by Anders Larson

Home: Text
bottom of page